William Mckee - Net Worth and Insider Trading

William Mckee Net Worth

The estimated net worth of William Mckee is at least $273,124 dollars as of 2024-05-22. William Mckee is the Director of Assertio Holdings Inc and owns about 238,780 shares of Assertio Holdings Inc (ASRT) stock worth over $243,388. William Mckee is also the CFO of C4 Therapeutics Inc and owns about 5,263 shares of C4 Therapeutics Inc (CCCC) stock worth over $29,736. Details can be seen in William Mckee's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William Mckee has not made any transactions after 2023-08-14 and currently still holds the listed stock(s).

Transaction Summary of William Mckee

To

William Mckee Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William Mckee owns 5 companies in total, including C4 Therapeutics Inc (CCCC) , Aileron Therapeutics Inc (ALRN) , and Assertio Holdings Inc (ASRT) among others .

Click here to see the complete history of William Mckee’s form 4 insider trades.

Insider Ownership Summary of William Mckee

Ticker Comapny Transaction Date Type of Owner
CCCC C4 Therapeutics Inc 2020-10-06 Chief Financial Officer
ALRN Aileron Therapeutics Inc 2019-06-19 director
ASRT Assertio Holdings Inc 2023-08-14 director
2014-05-22 director
2014-04-10 director

William Mckee Latest Holdings Summary

William Mckee currently owns a total of 2 stocks. Among these stocks, William Mckee owns 238,780 shares of Assertio Holdings Inc (ASRT) as of August 14, 2023, with a value of $243,388 and a weighting of 89.11%. William Mckee also owns 5,263 shares of C4 Therapeutics Inc (CCCC) as of October 6, 2020, with a value of $29,736 and a weighting of 10.89%.

Latest Holdings of William Mckee

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ASRT Assertio Holdings Inc 2023-08-14 238,780 1.02 243,388
CCCC C4 Therapeutics Inc 2020-10-06 5,263 5.65 29,736

Holding Weightings of William Mckee


William Mckee Form 4 Trading Tracker

According to the SEC Form 4 filings, William Mckee has made a total of 2 transactions in Assertio Holdings Inc (ASRT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Assertio Holdings Inc is the sale of 22,000 shares on August 14, 2023, which brought William Mckee around $69,080.

According to the SEC Form 4 filings, William Mckee has made a total of 1 transactions in C4 Therapeutics Inc (CCCC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in C4 Therapeutics Inc is the acquisition of 5,263 shares on October 6, 2020, which cost William Mckee around $99,997.

Insider Trading History of William Mckee

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William Mckee Trading Performance

GuruFocus tracks the stock performance after each of William Mckee's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Mckee is 24.07%. GuruFocus also compares William Mckee's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Mckee within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William Mckee's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William Mckee

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.04
Relative Return to S&P 500(%) -4.38

William Mckee Ownership Network

Ownership Network List of William Mckee

No Data

Ownership Network Relation of William Mckee


William Mckee Owned Company Details

What does C4 Therapeutics Inc do?

Who are the key executives at C4 Therapeutics Inc?

William Mckee is the Chief Financial Officer of C4 Therapeutics Inc. Other key executives at C4 Therapeutics Inc include Chief Financial Officer Kendra Adams , Chief Accounting Officer Mark Mossler , and Chief Medical Officer Leonard Reyno .

C4 Therapeutics Inc (CCCC) Insider Trades Summary

Over the past 18 months, William Mckee made no insider transaction in C4 Therapeutics Inc (CCCC). Other recent insider transactions involving C4 Therapeutics Inc (CCCC) include a net purchase of 5,667 shares made by Utpal Koppikar ,

In summary, during the past 3 months, insiders sold 0 shares of C4 Therapeutics Inc (CCCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of C4 Therapeutics Inc (CCCC) were sold and 5,667 shares were bought by its insiders, resulting in a net purchase of 5,667 shares.

C4 Therapeutics Inc (CCCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

C4 Therapeutics Inc Insider Transactions

No Available Data

William Mckee Mailing Address

Above is the net worth, insider trading, and ownership report for William Mckee. Currently GuruFocus does not have mailing address information for William Mckee.

Discussions on William Mckee

No discussions yet.